A detailed history of Mutual Of America Capital Management LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 11,242 shares of MDGL stock, worth $3.91 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,242
Previous 11,348 0.93%
Holding current value
$3.91 Million
Previous $3.18 Million 24.98%
% of portfolio
0.03%
Previous 0.04%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$212.22 - $292.96 $22,495 - $31,053
-106 Reduced 0.93%
11,242 $2.39 Million
Q2 2024

Aug 09, 2024

SELL
$193.33 - $291.99 $94,925 - $143,367
-491 Reduced 4.15%
11,348 $3.18 Million
Q1 2024

May 02, 2024

SELL
$171.37 - $283.23 $165,200 - $273,033
-964 Reduced 7.53%
11,839 $3.16 Million
Q4 2023

Jan 26, 2024

SELL
$120.4 - $237.13 $68,868 - $135,638
-572 Reduced 4.28%
12,803 $2.96 Million
Q3 2023

Nov 09, 2023

SELL
$146.04 - $225.78 $116,247 - $179,720
-796 Reduced 5.62%
13,375 $1.95 Million
Q2 2023

Aug 11, 2023

SELL
$203.88 - $312.0 $220,598 - $337,584
-1,082 Reduced 7.09%
14,171 $3.27 Million
Q1 2023

May 04, 2023

SELL
$231.06 - $307.08 $161,973 - $215,263
-701 Reduced 4.39%
15,253 $3.7 Million
Q4 2022

Feb 10, 2023

BUY
$58.39 - $296.54 $12,553 - $63,756
215 Added 1.37%
15,954 $4.63 Million
Q3 2022

Nov 08, 2022

SELL
$60.57 - $79.51 $86,615 - $113,699
-1,430 Reduced 8.33%
15,739 $1.02 Million
Q2 2022

Aug 10, 2022

SELL
$58.04 - $100.2 $7,487 - $12,925
-129 Reduced 0.75%
17,169 $1.23 Million
Q1 2022

May 02, 2022

SELL
$55.89 - $101.89 $42,029 - $76,621
-752 Reduced 4.17%
17,298 $1.7 Million
Q4 2021

Feb 03, 2022

SELL
$72.34 - $95.09 $12,225 - $16,070
-169 Reduced 0.93%
18,050 $1.53 Million
Q3 2021

Nov 10, 2021

SELL
$78.35 - $105.02 $20,684 - $27,725
-264 Reduced 1.43%
18,219 $1.45 Million
Q2 2021

Aug 06, 2021

SELL
$97.2 - $137.59 $77,176 - $109,246
-794 Reduced 4.12%
18,483 $1.8 Million
Q1 2021

May 13, 2021

SELL
$108.54 - $125.2 $115,703 - $133,463
-1,066 Reduced 5.24%
19,277 $2.26 Million
Q4 2020

Feb 12, 2021

BUY
$110.06 - $133.7 $310,479 - $377,167
2,821 Added 16.1%
20,343 $2.26 Million
Q3 2020

Nov 13, 2020

SELL
$99.78 - $124.21 $300,238 - $373,747
-3,009 Reduced 14.66%
17,522 $2.08 Million
Q2 2020

Aug 06, 2020

SELL
$60.13 - $125.71 $36,679 - $76,683
-610 Reduced 2.89%
20,531 $2.33 Million
Q1 2020

May 11, 2020

SELL
$66.76 - $93.49 $62,086 - $86,945
-930 Reduced 4.21%
21,141 $1.41 Million
Q4 2019

Feb 11, 2020

SELL
$84.28 - $118.5 $12,894 - $18,130
-153 Reduced 0.69%
22,071 $2.01 Million
Q3 2019

Nov 14, 2019

BUY
$84.4 - $106.53 $638,823 - $806,325
7,569 Added 51.65%
22,224 $1.92 Million
Q2 2019

Aug 12, 2019

BUY
$91.13 - $142.5 $911 - $1,425
10 Added 0.07%
14,655 $1.54 Million
Q1 2019

May 13, 2019

BUY
$103.48 - $143.84 $1.08 Million - $1.5 Million
10,445 Added 248.69%
14,645 $1.83 Million
Q2 2018

Aug 09, 2018

BUY
$101.55 - $313.9 $426,510 - $1.32 Million
4,200 New
4,200 $1.18 Million

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.94B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.